ArticleBioMed research international2015

Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.

Daniela Belotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.